IMM-BCP-01, a patient-derived anti-SARS-CoV-2 antibody cocktail, is active across variants of concern including Omicron BA.1 and BA.2

Added 38 days ago (01.07.2022)
Authors: Pavel A Nikitin; Jillian M DiMuzio; John P Dowling; Nirja B Patel; Jamie L Bingaman-Steele; Baron C Heimbach; Noeleya Henriquez; Chris Nicolescu; Antonio Polley; Eden L Sikorski; Raymond J Howanski; Mitchell Nath; Halley Shukla; Suzanne M Scheaffer; James P Finn; Li-Fang Liang; Todd Smith; Nadia Storm; Lindsay G A McKay; Rebecca I Johnson; Lauren E Malsick; Anna N Honko; Anthony Griffiths; Michael S Diamond; Purnanand Sarma; Dennis H Geising; Michael J Morin; Matthew K Robinson
Read article